المؤلفون: Maartje W. Rohaan, Troels H. Borch, Joost H. van den Berg, Özcan Met, Rob Kessels, Marnix H. Geukes Foppen, Joachim Stoltenborg Granhøj, Bastiaan Nuijen, Cynthia Nijenhuis, Inge Jedema, Maaike van Zon, Saskia Scheij, Jos H. Beijnen, Marten Hansen, Carlijn Voermans, Inge M. Noringriis, Tine J. Monberg, Rikke B. Holmstroem, Lidwina D.V. Wever, Marloes van Dijk, Lindsay G. Grijpink-Ongering, Ludy H.M. Valkenet, Alejandro Torres Acosta, Matthias Karger, Jessica S.W. Borgers, Renske M.T. ten Ham, Valesca P. Retèl, Wim H. van Harten, Ferry Lalezari, Harm van Tinteren, Astrid A.M. van der Veldt, Geke A.P. Hospers, Marion A.M. Stevense-den Boer, Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts, Djura Piersma, Alfons J.M. van den Eertwegh, Jan-Willem B. de Groot, Gerard Vreugdenhil, Ellen Kapiteijn, Marye J. Boers-Sonderen, W. Edward Fiets, Franchette W.P.J. van den Berkmortel, Eva Ellebaek, Lisbet R. Hölmich, Alexander C.J. van Akkooi, Winan J. van Houdt, Michel W.J.M. Wouters, Johannes V. van Thienen, Christian U. Blank, Aafke Meerveld-Eggink, Sebastian Klobuch, Sofie Wilgenhof, Ton N. Schumacher, Marco Donia, Inge Marie Svane, John B.A.G. Haanen

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical Biochemistry, CCA - Cancer Treatment and Quality of Life, AII - Cancer immunology, Landsteiner Laboratory, General Internal Medicine, Health Technology & Services Research, Health Technology Assessment (HTA), Medical Oncology, Erasmus MC other, Surgery, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: New England Journal of Medicine, 387(23), 2113-2125. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 387, 2113-2125
New England journal of medicine, 387(23), 2113-2125. Massachussetts Medical Society
Rohaan, M W, Borch, T H, Van Den Berg, J H, Met, Ö, Kessels, R, Geukes Foppen, M H, Stoltenborg Granhøj, J, Nuijen, B, Nijenhuis, C, Jedema, I, Van Zon, M, Scheij, S, Beijnen, J H, Hansen, M, Voermans, C, Noringriis, I M, Monberg, T J, Holmstroem, R B, Wever, L D V, Van Dijk, M, Grijpink-Ongering, L G, Valkenet, L H M, Torres Acosta, A, Karger, M, Borgers, J S W, Ten Ham, R M T, Retèl, V P, Van Harten, W H, Lalezari, F, Van Tinteren, H, Van Der Veldt, A A M, Hospers, G A P, Stevense-Den Boer, M A M, Suijkerbuijk, K P M, Aarts, M J B, Piersma, D, Van Den Eertwegh, A J M, De Groot, J W B, Vreugdenhil, G, Kapiteijn, E, Boers-Sonderen, M J, Fiets, W E, Van Den Berkmortel, F W P J, Ellebaek, E, Hölmich, L R, Van Akkooi, A C J, Van Houdt, W J, Wouters, M W J M, Van Thienen, J V, Blank, C U, Meerveld-Eggink, A, Klobuch, S, Wilgenhof, S, Schumacher, T N, Donia, M, Svane, I M & Haanen, J B A G 2022, ' Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma. ', New England Journal of Medicine, vol. 387, no. 23, pp. 2113-2125 . https://doi.org/10.1056/NEJMoa2210233Test
The New England journal of medicine, 387(23), 2113-2125. Massachussetts Medical Society
New England Journal of Medicine, 387(23), 2113-2125. MASSACHUSETTS MEDICAL SOCIETY
The New England Journal of Medicine, 387, 23, pp. 2113-2125

مصطلحات موضوعية: Adoptive, Cell- and Tissue-Based Therapy, Outcomes, Dermatology, Metastatic melanoma, Guidelines, Immunotherapy, Adoptive, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Lymphocytes, Tumor-Infiltrating, SDG 3 - Good Health and Well-being, Adoption, Humans, Melanoma/drug therapy, Lymphocytes, Tumor-Infiltrating, Melanoma, Skin Cancer, Treatments in Oncology, Cancer, General Medicine, Complete responses, Hematology/Oncology, Ipilimumab, n/a OA procedure, Adoptive cell therapy, Nivolumab, Ipilimumab/adverse effects, Immunotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf28a71e5a16116e2b0f59cdac9485aTest
https://research.rug.nl/en/publications/9033fdbd-9e6f-4cca-a35b-50890da9f292Test

المؤلفون: Thomas F. Eleveld, Lindy Vernooij, Linda Schild, Bianca Koopmans, Lindy K. Alles, Marli E. Ebus, Rana Dandis, Harm van Tinteren, Huib N. Caron, Jan Koster, Max M. van Noesel, Godelieve A. M. Tytgat, Selma Eising, Rogier Versteeg, M. Emmy M. Dolman, Jan J. Molenaar

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, MEK, b-cell lymphoma 2 (BCL-2), neuroblastoma, trametinib (PubChem CID: 11707110), navitoclax (ABT-263, PubChem CID: 24978538), venetoclax (ABT-199, PubChem CID: 49846579), synergy, pediatric cancer

العلاقة: https://figshare.com/articles/dataset/DataSheet_1_MEK_inhibition_causes_BIM_stabilization_and_increased_sensitivity_to_BCL-2_family_member_inhibitors_in_RAS-MAPK-mutated_neuroblastoma_docx/22133915Test

الإتاحة: https://doi.org/10.3389/fonc.2023.1130034.s001Test
https://figshare.com/articles/dataset/DataSheet_1_MEK_inhibition_causes_BIM_stabilization_and_increased_sensitivity_to_BCL-2_family_member_inhibitors_in_RAS-MAPK-mutated_neuroblastoma_docx/22133915Test

المؤلفون: Thomas F. Eleveld, Lindy Vernooij, Linda Schild, Bianca Koopmans, Lindy K. Alles, Marli E. Ebus, Rana Dandis, Harm van Tinteren, Huib N. Caron, Jan Koster, Max M. van Noesel, Godelieve A. M. Tytgat, Selma Eising, Rogier Versteeg, M. Emmy M. Dolman, Jan J. Molenaar

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, MEK, b-cell lymphoma 2 (BCL-2), neuroblastoma, trametinib (PubChem CID: 11707110), navitoclax (ABT-263, PubChem CID: 24978538), venetoclax (ABT-199, PubChem CID: 49846579), synergy, pediatric cancer

العلاقة: https://figshare.com/articles/dataset/Table_1_MEK_inhibition_causes_BIM_stabilization_and_increased_sensitivity_to_BCL-2_family_member_inhibitors_in_RAS-MAPK-mutated_neuroblastoma_xlsx/22133918Test

الإتاحة: https://doi.org/10.3389/fonc.2023.1130034.s002Test
https://figshare.com/articles/dataset/Table_1_MEK_inhibition_causes_BIM_stabilization_and_increased_sensitivity_to_BCL-2_family_member_inhibitors_in_RAS-MAPK-mutated_neuroblastoma_xlsx/22133918Test

المؤلفون: Anouk Steur, Paulien A. M. A. Raymakers-Janssen, Martin C. J. Kneyber, Sandra Dijkstra, Job B. M. van Woensel, Dick A. van Waardenburg, Cornelis P. van de Ven, Alida F. W. van der Steeg, Marc Wijnen, Marc R. Lilien, Ronald R. de Krijger, Harm van Tinteren, Annemieke S. Littooij, Geert O. Janssens, Annemarie M. L. Peek, Godelieve A. M. Tytgat, Annelies M. Mavinkurve-Groothuis, Martine van Grotel, Marry M. van den Heuvel-Eibrink, Roelie M. Wösten-van Asperen

المساهمون: Paediatric Intensive Care, ARD - Amsterdam Reproduction and Development, Paediatric Oncology, CCA - Cancer Treatment and Quality of Life, Kindergeneeskunde, MUMC+: MA Medische Staf Kindergeneeskunde (9), RS: NUTRIM - R1 - Obesity, diabetes and cardiovascular health, Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE), Groningen Energy & Sustainability Programme, Pediatrics

المصدر: Cancers; Volume 14; Issue 4; Pages: 943
Steur, A, Raymakers-Janssen, P A M A, Kneyber, M C J, Dijkstra, S, van Woensel, J B M, van Waardenburg, D A, van de Ven, C P, van der Steeg, A F W, Wijnen, M, Lilien, M R, de Krijger, R R, van Tinteren, H, Littooij, A S, Janssens, G O, Peek, A M L, Tytgat, G A M, Mavinkurve-Groothuis, A M, van Grotel, M, van den Heuvel-Eibrink, M M & Wösten-van Asperen, R M 2022, ' Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line Therapy ', Cancers, vol. 14, no. 4, 943 . https://doi.org/10.3390/cancers14040943Test
Cancers, 14(4):943. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, 14(4):943. MDPI AG

مصطلحات موضوعية: PROTOCOL, SURVIVORS, Cancer Research, SIOP WT 2001, HYPERTENSION, NEPHRECTOMY, INTERMEDIATE-RISK, Wilms tumor, intensive care, pediatric oncology, risk factors, outcome, Pediatric oncology, CANCER, CLASSIFICATION, RENAL TUMORS, Oncology, Risk factors, INTRACARDIAC EXTENSION, Intensive care, Outcome

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48657ad544059ae825500582a0fdc582Test
https://doi.org/10.3390/cancers14040943Test

المؤلفون: Prakriti Roy (11944506), Sophie E. van Peer (11944509), Martin M. de Witte (11944512), Godelieve A. M. Tytgat (11322134), Henrike E. Karim-Kos (3213510), Martine van Grotel (4092808), Cees P. van de Ven (4862965), Annelies M. C. Mavinkurve-Groothuis (11944515), Johannes H. M. Merks (11944518), Roland P. Kuiper (11944521), Janna A. Hol (11944524), Geert O. R. Janssens (11944527), Ronald R. de Krijger (9652435), Marjolijn C. J. Jongmans (11944530), Jarno Drost (9261587), Alida F. W. van der Steeg (10262994), Annemieke S. Littooij (11944533), Marc H. W. A. Wijnen (11944536), Harm van Tinteren (3481451), Marry M. van den Heuvel-Eibrink (7391279)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Marine Biology, Cancer, Science Policy, Biological Sciences not elsewhere classified, central radiology review, central pathology review, although survival rates, renal mass diagnosed, multidisciplinary decision making, high quality diagnostics, netherlands cancer registry, including 1 patient, first 5 years, year &# 8217, renal tumors led, pediatric oncology care, identified 164 patients, renal tumors, pediatric oncology, renal tumor, old patient, multidisciplinary consensus, molecular diagnostics, first five, care led, 19 years

العلاقة: https://figshare.com/articles/figure/Flow_diagram_of_presentation_and_surgical_management_of_patients_/18338481Test

الإتاحة: https://doi.org/10.1371/journal.pone.0261729.g003Test

المؤلفون: Prakriti Roy (11944506), Sophie E. van Peer (11944509), Martin M. de Witte (11944512), Godelieve A. M. Tytgat (11322134), Henrike E. Karim-Kos (3213510), Martine van Grotel (4092808), Cees P. van de Ven (4862965), Annelies M. C. Mavinkurve-Groothuis (11944515), Johannes H. M. Merks (11944518), Roland P. Kuiper (11944521), Janna A. Hol (11944524), Geert O. R. Janssens (11944527), Ronald R. de Krijger (9652435), Marjolijn C. J. Jongmans (11944530), Jarno Drost (9261587), Alida F. W. van der Steeg (10262994), Annemieke S. Littooij (11944533), Marc H. W. A. Wijnen (11944536), Harm van Tinteren (3481451), Marry M. van den Heuvel-Eibrink (7391279)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Marine Biology, Cancer, Science Policy, Biological Sciences not elsewhere classified, central radiology review, central pathology review, although survival rates, renal mass diagnosed, multidisciplinary decision making, high quality diagnostics, netherlands cancer registry, including 1 patient, first 5 years, year &# 8217, renal tumors led, pediatric oncology care, identified 164 patients, renal tumors, pediatric oncology, renal tumor, old patient, multidisciplinary consensus, molecular diagnostics, first five, care led, 19 years

العلاقة: https://figshare.com/articles/figure/Distribution_of_renal_cancer_subtypes_in_patients_with_suspicion_of_renal_tumor_/18338475Test

الإتاحة: https://doi.org/10.1371/journal.pone.0261729.g001Test

المؤلفون: Prakriti Roy (11944506), Sophie E. van Peer (11944509), Martin M. de Witte (11944512), Godelieve A. M. Tytgat (11322134), Henrike E. Karim-Kos (3213510), Martine van Grotel (4092808), Cees P. van de Ven (4862965), Annelies M. C. Mavinkurve-Groothuis (11944515), Johannes H. M. Merks (11944518), Roland P. Kuiper (11944521), Janna A. Hol (11944524), Geert O. R. Janssens (11944527), Ronald R. de Krijger (9652435), Marjolijn C. J. Jongmans (11944530), Jarno Drost (9261587), Alida F. W. van der Steeg (10262994), Annemieke S. Littooij (11944533), Marc H. W. A. Wijnen (11944536), Harm van Tinteren (3481451), Marry M. van den Heuvel-Eibrink (7391279)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Marine Biology, Cancer, Science Policy, Biological Sciences not elsewhere classified, central radiology review, central pathology review, although survival rates, renal mass diagnosed, multidisciplinary decision making, high quality diagnostics, netherlands cancer registry, including 1 patient, first 5 years, year &# 8217, renal tumors led, pediatric oncology care, identified 164 patients, renal tumors, pediatric oncology, renal tumor, old patient, multidisciplinary consensus, molecular diagnostics, first five, care led, 19 years

العلاقة: https://figshare.com/articles/dataset/Characteristics_overview_of_registered_patients_with_suspicion_for_a_renal_tumor_2015_2019_/18338487Test

الإتاحة: https://doi.org/10.1371/journal.pone.0261729.t001Test

المؤلفون: Prakriti Roy (11944506), Sophie E. van Peer (11944509), Martin M. de Witte (11944512), Godelieve A. M. Tytgat (11322134), Henrike E. Karim-Kos (3213510), Martine van Grotel (4092808), Cees P. van de Ven (4862965), Annelies M. C. Mavinkurve-Groothuis (11944515), Johannes H. M. Merks (11944518), Roland P. Kuiper (11944521), Janna A. Hol (11944524), Geert O. R. Janssens (11944527), Ronald R. de Krijger (9652435), Marjolijn C. J. Jongmans (11944530), Jarno Drost (9261587), Alida F. W. van der Steeg (10262994), Annemieke S. Littooij (11944533), Marc H. W. A. Wijnen (11944536), Harm van Tinteren (3481451), Marry M. van den Heuvel-Eibrink (7391279)

مصطلحات موضوعية: Medicine, Cell Biology, Pharmacology, Biotechnology, Marine Biology, Cancer, Science Policy, Biological Sciences not elsewhere classified, central radiology review, central pathology review, although survival rates, renal mass diagnosed, multidisciplinary decision making, high quality diagnostics, netherlands cancer registry, including 1 patient, first 5 years, year &# 8217, renal tumors led, pediatric oncology care, identified 164 patients, renal tumors, pediatric oncology, renal tumor, old patient, multidisciplinary consensus, molecular diagnostics, first five, care led, 19 years

العلاقة: https://figshare.com/articles/figure/Age_distribution_of_registered_patients_per_tumor_sub-types_/18338478Test

الإتاحة: https://doi.org/10.1371/journal.pone.0261729.g002Test

المؤلفون: Harm van Tinteren, Jesper Brok, Marta Lopez-Yurda, Kathy Pritchard-Jones, Øystein E. Olsen, Arnauld Verschuur, Norbert Graf, Taryn D. Treger, Beatriz de Camargo, Christophe Bergeron, Rhoikos Furtwängler, Marry M. van den Heuvel-Eibrink, Filippo Spreafico

المصدر: The Lancet Oncology. 19:1072-1081

مصطلحات موضوعية: 0301 basic medicine, Database, medicine.diagnostic_test, business.industry, medicine.medical_treatment, Cancer, Retrospective cohort study, Physical examination, computer.software_genre, medicine.disease, Asymptomatic, Nephrectomy, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, medicine, Abdomen, medicine.symptom, business, computer, Subclinical infection

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3430fbb0779f39076305880983d22fa5Test
https://doi.org/10.1016/s1470-2045Test(18)30293-6

المؤلفون: Caroline M. Seynaeve, Elsken van der Wall, Elisabeth G.E. de Vries, Wim M. Smit, Jacobus J M van der Hoeven, Vivianne C. G. Tjan-Heijnen, Judith R. Kroep, Harm van Tinteren, Flora E. van Leeuwen, Judy N. Jacobse, Jourik A. Gietema, Carolien P. Schröder, Lars C Steggink, Gabe S. Sonke, Maartje J. Hooning, Tessa G Steenbruggen, Sabine C. Linn, Michael Schaapveld, Inge R Konings, Agnes Jager, Adriaan Bins

المساهمون: Internal medicine, Medical oncology, CCA - Cancer Treatment and quality of life, Oncology, CCA - Cancer Treatment and Quality of Life, Medical Oncology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Medische Oncologie (9), Interne Geneeskunde

المصدر: Jama Oncology, 6, 4, pp. 528-534
JAMA Oncology, 6(4), 528-534. American Medical Association
Steenbruggen, T G, Steggink, L C, Seynaeve, C M, Van Der Hoeven, J J M, Hooning, M J, Jager, A, Konings, I R, Kroep, J R, Smit, W M, Tjan-Heijnen, V C G, Van Der Wall, E, Bins, A D, Linn, S C, Schaapveld, M, Jacobse, J N, Van Leeuwen, F E, Schröder, C P, Van Tinteren, H, De Vries, E G E, Sonke, G S & Gietema, J A 2020, ' High-Dose Chemotherapy with Hematopoietic Stem Cell Transplant in Patients with High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes : 20-Year Follow-up of a Phase 3 Randomized Clinical Trial ', JAMA Oncology, vol. 6, no. 4, pp. 528-534 . https://doi.org/10.1001/jamaoncol.2019.6276Test
JAMA oncology, 6(4), 528-534. American Medical Association
JAMA Oncology, 6(4), 528-534. AMER MEDICAL ASSOC
JAMA Oncol
Jama Oncology, 6, 528-534

مصطلحات موضوعية: Cancer Research, efficacy, 0302 clinical medicine, Cumulative incidence, Breast, 030212 general & internal medicine, Child, Original Investigation, support, benefit, Hazard ratio, Hematopoietic Stem Cell Transplantation, WOMEN, Middle Aged, Chemotherapy regimen, medicine.anatomical_structure, Oncology, Lymphatic Metastasis, 030220 oncology & carcinogenesis, Female, Fluorouracil, medicine.drug, Epirubicin, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Adult, medicine.medical_specialty, recurrence, Axillary lymph nodes, Cardiovascular Abnormalities, Breast Neoplasms, ThioTEPA, Disease-Free Survival, 03 medical and health sciences, Breast cancer, All institutes and research themes of the Radboud University Medical Center, SDG 3 - Good Health and Well-being, Internal medicine, conventional adjuvant chemotherapy, medicine, Humans, Cyclophosphamide, therapy, Dose-Response Relationship, Drug, business.industry, Cancer, medicine.disease, Axilla, Lymph Nodes, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc75b5fa1a0ce92730e37111e77ccec6Test
https://hdl.handle.net/2066/218567Test